FMP
Pear Therapeutics, Inc.
PEAR
NASDAQ
Inactive Equity
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
0.0292 USD
0 (0%)
About
ceo
Mr. Christopher D. T. Guiffre J.D., M.B.A., MBA
sector
Healthcare
industry
Medical - Healthcare Information Services
website
https://peartherapeutics.com
exchange
NASDAQ
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
CIK
0001835567
ISIN
US7047231052
CUSIP
704723105
Address
200 State Street
Phone
617 925 7848
Country
US
Employee
200
IPO Date
Mar 31, 2021
Key Executives
